본문 바로가기
KERD
논문KCI 등재

대한천식알레르기학회 알레르기비염 진료지침: 파트 1. 약물치료의 업데이트

KAAACI Allergic Rhinitis Guidelines: Part 1. Update in pharmacotherapy

1

조회

0

다운로드

1

인용

0

참고문헌

키워드

주제분류소아과학

초록

The prevalence of allergic rhinitis (AR) and the socioeconomic burden associated with the medical cost and quality of life of AR have progressively increased. Therefore, practical guidelines for the appropriate management of AR need to be developed based on scientific evidence considering the real-world environment, values, and preferences of patients and physicians. The Korean Academy of Asthma, Allergy and Clinical Immunology revised clinical guidelines for AR to address key clinical questions of the management of AR. Part 1 of the revised guideline covers the pharmacological management of patients with AR in Korea. Through a meta-analysis and a systematic review, we made 4 recommendations for AR pharmacotherapy, including intranasal corticosteroid (INCS)/intranasal antihistamine combination therapy, oral antihistamine/INCS combination therapy, leukotriene receptor antagonist treatment in AR patients with asthma, and prophylactic treatment for patients with pollen-induced AR. However, all recommendations are conditional because of the low or very low evidence of certainty. Well-designed and strictly executed randomized controlled trials are needed to measure and report appropriate outcomes.

Abstract

The prevalence of allergic rhinitis (AR) and the socioeconomic burden associated with the medical cost and quality of life of AR have progressively increased. Therefore, practical guidelines for the appropriate management of AR need to be developed based on scientific evidence considering the real-world environment, values, and preferences of patients and physicians. The Korean Academy of Asthma, Allergy and Clinical Immunology revised clinical guidelines for AR to address key clinical questions of the management of AR. Part 1 of the revised guideline covers the pharmacological management of patients with AR in Korea. Through a meta-analysis and a systematic review, we made 4 recommendations for AR pharmacotherapy, including intranasal corticosteroid (INCS)/intranasal antihistamine combination therapy, oral antihistamine/INCS combination therapy, leukotriene receptor antagonist treatment in AR patients with asthma, and prophylactic treatment for patients with pollen-induced AR. However, all recommendations are conditional because of the low or very low evidence of certainty. Well-designed and strictly executed randomized controlled trials are needed to measure and report appropriate outcomes.

참고문헌 (60)

  1. "Prevalence of allergic disease and allergen-specific IgE positive rate in adults" (2022)[URL]
  2. "17th Korea Youth Risk Behavior Web-based Survey" (2021)[URL]
  3. "Healthy lifestyle information" (2020)[URL]
  4. 유광하, "Burden of Respiratory Disease in Korea: An Observational Study on Allergic Rhinitis, Asthma, COPD, and Rhinosinusitis", Allergy, Asthma & Immunology Research, 8(6), pp.527~534 (2016), 대한천식알레르기학회
  5. Brożek JL, "Allergic Rhinitis and its Impact on Asthma(ARIA)guidelines-2016 revision", J Allergy Clin Immunol, 140, pp.950~958 (2017)
  6. 양현종, "Unmet Primary Physicians’ Needs for Allergic Rhinitis Care in Korea", Allergy, Asthma & Immunology Research, 9(3), pp.265~271 (2017), 대한천식알레르기학회
  7. "Clinical diagnostic guidelines for management of allergic rhinitis" (2015)[URL]
  8. Wheatley LM, "Clinical practice. Allergic rhinitis", N Engl J Med, 372, pp.456~463 (2015)
  9. Bende M, "A randomized comparison of the effects of budesonide and mometasone furoate aqueous nasal sprays on nasal peak flow rate and symptoms in perennial allergic rhinitis", Ann Allergy Asthma Immunol, 88, pp.617~623 (2002)
  10. Bousquet J, "Next-generation Allergic Rhinitis and Its Impact on Asthma(ARIA)guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation(GRADE)and real-world evidence", J Allergy Clin Immunol, 145, pp.70~80 (2020)
  11. Ratner PH, "Combination therapy with azelastine hydrochloride nasal spray and fluticasone propionate nasal spray in the treatment of patients with seasonal allergic rhinitis", Ann Allergy Asthma Immunol, 100, pp.74~81 (2008)
  12. Hampel FC, "Double-blind, placebo-controlled study of azelastine and fluticasone in a single nasal spray delivery device", Ann Allergy Asthma Immunol, 105, pp.168~173 (2010)
  13. Salapatek AM, "Solubilized nasal steroid(CDX-947)when combined in the same solution nasal spray with an antihistamine(CDX-313)provides improved, fast-acting symptom relief in patients with allergic rhinitis", Allergy Asthma Proc, 32, pp.221~229 (2011)
  14. Carr W, "A novel intranasal therapy of azelastine with fluticasone for the treatment of allergic rhinitis", J Allergy Clin Immunol, 129, pp.1282~1289 (2012)
  15. Karpishchenko SA, "The effectiveness of the combination of azelastine hydrochloride and mometasone furoate for the intranasal application in the patients presenting with seasonal allergic rhinitis", Vestn Otorinolaringol, 82, pp.44~47 (2017)
  16. Gross GN, "Efficacy and safety of olopatadine-mometasone combination nasal spray for the treatment of seasonal allergic rhinitis", Ann Allergy Asthma Immunol, 122, pp.630~638 (2019)
  17. Hampel FC, "Olopatadine-mometasone combination nasal spray : evaluation of efficacy and safety in patients with seasonal allergic rhinitis", Allergy Asthma Proc, 40, pp.261~272 (2019)
  18. Andrews CP, "Efficacy and safety of twice-daily and once-daily olopatadine-mometasone combination nasal spray for seasonal allergic rhinitis", Ann Allergy Asthma Immunol, 124, pp.171~178 (2020)
  19. Dalvi RG, "Comparative study of topical treatment in allergic rhinitis using azelastine and fluticasone in a combination verses fluticasone propionate alone", J Krishna Inst Med Sci Univ, 8, pp.21~28 (2019)
  20. "A proof of concept study to assess effect of fluticasone furoate (FF)/levocabastine fixed dose combination (FDC) compared with levocabastine and FF alone in subjects with allergic rhinitis (AR)" (2013)[URL]
  21. "Bepotastine besilate-corticosteroid nasal spray combination compared to placebo, bepotastine besilate nasal spray, and corticosteroid nasal spray in the treatment of patients with seasonal allergic rhinitis" (2012)[URL]
  22. Havle AD, "Topical treatment using antihistaminic, steroid and a combination of both in allergic rhinitis-a double-blind randomized controlled trial", Int J Pharm Sci Res, 11, pp.1917~1921 (2020)
  23. "3 Month safety study of dymista nasal spray and fluticasone propionate in children 4-11 years of age with allergic rhinitis" (2015)[URL]
  24. Kim M, "Intranasal antihistamine and corticosteroid to treat allergic rhinitis : a systematic review and meta-analysis", Allergy, 77, pp.3436~3440 (2022)
  25. Navarro A, "Clinical use of oral antihistamines and intranasal corticosteroids in patients with allergic rhinitis", J Investig Allergol Clin Immunol, 21, pp.363~369 (2011)
  26. Barnes ML, "Effects of levocetirizine as add-on therapy to fluticasone in seasonal allergic rhinitis", Clin Exp Allergy, 36, pp.676~684 (2006)
  27. Di Lorenzo G, "Randomized placebo-controlled trial comparing fluticasone aqueous nasal spray in mono-therapy, fluticasone plus cetirizine, fluticasone plus montelukast and cetirizine plus montelukast for seasonal allergic rhinitis", Clin Exp Allergy, 34, pp.259~267 (2004)
  28. 김창훈, "Comparison of Intranasal Ciclesonide, Oral Levocetirizine, and Combination Treatment for Allergic Rhinitis", Allergy, Asthma & Immunology Research, 7(2), pp.158~166 (2015), 대한천식알레르기학회
  29. Modgill V, "Efficacy and safety of montelukast add-on therapy in allergic rhinitis", Methods Find Exp Clin Pharmacol, 32, pp.669~674 (2010)
  30. Ratner PH, "A comparison of the efficacy of fluticasone propionate aqueous nasal spray and loratadine, alone and in combination, for the treatment of seasonal allergic rhinitis", J Fam Pract, 47, pp.118~125 (1998)
  31. Simpson RJ, "Budesonide and terfenadine, separately and in combination, in the treatment of hay fever", Ann Allergy, 73, pp.497~502 (1994)
  32. Anolik R, "Clinical benefits of combination treatment with mometasone furoate nasal spray and loratadine vs monotherapy with mometasone furoate in the treatment of seasonal allergic rhinitis", Ann Allergy Asthma Immunol, 100, pp.264~271 (2008)
  33. Du K, "Intranasal antihistamine is superior to oral H1 antihistamine as an add-on therapy to intranasal corticosteroid for treating allergic rhinitis", Ann Allergy Asthma Immunol, 125, pp.589~596 (2020)
  34. Juniper EF, "Interpretation of rhinoconjunctivitis quality of life questionnaire data", J Allergy Clin Immunol, 98, pp.843~845 (1996)
  35. Dahlén SE, "Cysteinyl leukotrienes as common mediators of asthma and allergic disease", Clin Exp Allergy Rev, 3, pp.69~73 (2003)
  36. Philip G, "The effect of montelukast on rhinitis symptoms in patients with asthma and seasonal allergic rhinitis", Curr Med Res Opin, 20, pp.1549~1558 (2004)
  37. Nathan RA, "Fluticasone propionate nasal spray is superior to montelukast for allergic rhinitis while neither affects overall asthma control", Chest, 128, pp.1910~1920 (2005)
  38. Katial RK, "Adding montelukast to fluticasone propionate", salmeterol for control of asthma and seasonal allergic rhinitis, 2010, pp.31, 68~75
  39. "FDA requires Boxed Warning about serious mental health side effects for asthma and allergy drug montelukast (Singulair); advises restricting use for allergic rhinitis" (2020)[URL]
  40. Sansing-Foster V, "Risk of psychiatric adverse events among montelukast users", J Allergy Clin Immunol Pract, 9, pp.385~393 (2021)
  41. Li L, "Efficacy of montelukast as prophylactic treatment for seasonal allergic rhinitis", Ear Nose Throat J, 97, pp.E12~ (2018)
  42. Yoshimura T, "Efficacy of dexamethasone cipecilate nasal spray in the early treatment of seasonal allergic rhinitis", Jibi Inkoka Tembo, 56, pp.221~228 (2013)
  43. Yatomi M, "Evaluation of prophylactic treatment of Japanese cedar pollinosis with montelukast in 2012", Jibi Inkoka Tembo, 57, pp.73~81 (2014)
  44. Watanabe AK, "Prophylactic treatment with an anti-allergic agent(DAREN®)for patients with birch pollinosis", Pract Odontol, 93, pp.419~424 (2000)
  45. Takagi SN, "The effect of prophylactic treatment by cetirizine hydrochloride in patients with Japanese cedar pollinosis", Pract Odontol, 93, pp.879~885 (2000)
  46. Ohta N, "The effect of prophylactic treatment with fexofenadine on Japanese cedar pollinosis", Pract Otorhinolaryngol(Basel), 99, pp.501~508 (2006)
  47. Ohta N, "The effect of prophylactic treatment with bepotastine in patients with Japanese cedar pollinosis", Pract Otorhinolaryngol(Basel), 95, pp.531~537 (2002)
  48. Inagawa SN, "The efficacy of prophylactic adminstration for the treatment of Japanese cedar or Japanese cypress pollinosis", Pract Otorhinolaryngol(Basel), 99, pp.143~150 (2006)
  49. Hayashi S, "Prophylactic treatment with olopatadine hydrochloride for cedar pollenosis", Pract Otorhinolaryngol(Basel), 97, pp.655~662 (2004)
  50. Du Q, "Placebo-controlled assessment of somnolence effect of cetirizine : a meta-analysis", Int Forum Allergy Rhinol, 6, pp.871~879 (2016)
  51. Compalati E, "Systematic review on the efficacy of fexofenadine in seasonal allergic rhinitis : a meta-analysis of randomized, double-blind, placebo-controlled clinical trials", Int Arch Allergy Immunol, 156, pp.1~15 (2011)
  52. Seresirikachorn K, "Effects of H1 antihistamine addition to intranasal corticosteroid for allergic rhinitis : a systematic review and meta-analysis", Int Forum Allergy Rhinol, 8, pp.1083~1092 (2018)
  53. Svensson C, "Effects of topical budesonide and levocabastine on nasal symptoms and plasma exudation responses in seasonal allergic rhinitis", Allergy, 53, pp.367~374 (1998)
  54. Kurowski M, "Montelukast plus cetirizine in the prophylactic treatment of seasonal allergic rhinitis : influence on clinical symptoms and nasal allergic inflammation", Allergy, 59, pp.280~288 (2004)
  55. Jacobi HH, "Histamine and tryptase in nasal lavage fluid after allergen challenge : effect of 1 week of pretreatment with intranasal azelastine or systemic cetirizine", J Allergy Clin Immunol, 103, pp.768~772 (1999)
  56. Dolovich J, "Efficacy of loratadine versus placebo in the prophylactic treatment of seasonal allergic rhinitis", Ann Allergy, 73, pp.235~239 (1994)
  57. Ciprandi G, "Protective effect of loratadine on specific conjunctival provocation test", Int Arch Allergy Appl Immunol, 96, pp.344~347 (1991)
  58. Hashiguchi K, "The assessment of the optimal duration of early intervention with montelukast in the treatment of Japanese cedar pollinosis symptoms induced in an artificial exposure chamber", J Drug Assess, 1, pp.40~47 (2012)
  59. Graft D, "A placebo-and active-controlled randomized trial of prophylactic treatment of seasonal allergic rhinitis with mometasone furoate aqueous nasal spray", J Allergy Clin Immunol, 98, pp.724~731 (1996)

관련 논문AI추천

내과의사를 위한 알레르기비염 진료지침고영일대한내과학회 · 대한내과학회지2017 · 제92권 제5호A Survey of Korean Physicians’ Prescription Patterns for Allergic Rhinitis김동규, 김용민, 서민영, 안영민, 지혜미, 홍상덕대한이비인후과학회 · Clinical and Experimental Otorhinolaryngology2017 · 제10권 제4호대한천식알레르기학회 알레르기비염 진료지침: 파트 2. 비약물치료의 업데이트강성윤, 김도현, 김동규, 김미애, 김민지, 김봉성, 김수환, 김현정, 김효빈, 류광희, 박도양, 박상철, 양송이, 양현종, 이상민, 이용주, 이일환, 이현종, 전영준, 정수지, 최길순, 최정희대한 소아알레르기 호흡기학회 · Allergy Asthma & Respiratory Disease2023 · 제11권 제3호대한천식알레르기학회 설하면역요법 진료지침강성윤, 고영일, 김경훈, 김선태, 김주희, 남동호, 류광희, 민진영, 박경희, 박소영, 박중원, 성명순, 신유섭, 심정연, 안영민, 양은애, 이상민, 이영수, 이용원, 이화영, 정은희, 지혜미, 최선희, 최정희, 하은교, 한두희, 한만용, 대한천식알레르기학회 면역요법/알레르겐연구팀대한 소아알레르기 호흡기학회 · Allergy Asthma & Respiratory Disease2024 · 제12권 제3호국소알레르기비염의 최신지견조석현대한 소아알레르기 호흡기학회 · Allergy Asthma & Respiratory Disease2013 · 제1권 제4호알레르기 비염의 한의학적 관리를 위한 최신 지견김혜화, 송민영, 정창운, 조희근대한한방안이비인후피부과학회 · 한방안이비인후피부과학회지2016 · 제29권 제4호

이 간행물의 다른 논문 (6건)